VMAT2 Inhibitors for the Treatment of Tardive Dyskinesia
Psychiatric nurses are at the forefront of optimizing psychiatric care, including educating patients and caregivers on the risks of antipsychotic-induced movement disorders such as tardive dyskinesia (TD).
Barbara Warren +2 more
semanticscholar +1 more source
Treatment of tardive dyskinesias with vitamin E: A case series
Introduction Tardive dyskinesia is usually persistent, irreversible involuntary movement of the tongue, lips, face, trunk and extremities in patients taking long-term dopaminergic antagonist drugs.
B. Senol +3 more
doaj +1 more source
ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SYMPTOMS AND TARDIVE DYSKINESIA: ANALYSIS BASED ON A SPONTANEOUS REPORTING SYSTEM DATABASE IN JAPAN [PDF]
Yosuke Saga +3 more
openalex +2 more sources
Tardive Dyskinesia and Treatment Approaches [PDF]
Tardive dyskinesia is an iatrogenic movement disorder with an incompletely determined etiology. Involuntary movements can effect oral, lingual, facial, corporal muscles and can be permanent. Tardive dyskinesia is one of the most important side effects of
Mehmet Emin Demirkol +3 more
doaj +1 more source
Valbenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed? [PDF]
The objective of this systematic review was to describe the efficacy, tolerability, and safety of valbenazine for the treatment of tardive dyskinesia (TD).
Leslie Citrome
openalex +2 more sources
Factors Predicting the Efficacy of Valbenazine and Exacerbation of Tardive Dyskinesia After Valbenazine Discontinuation in Japanese Patients [PDF]
Yumi Watanabe +3 more
openalex +2 more sources
An Update on Tardive Dyskinesia: From Phenomenology to Treatment
Tardive dyskinesia (TD), characterized by oro-buccal-lingual stereotypy, can manifest in the form of akathisia, dystonia, tics, tremor, chorea, or as a combination of different types of abnormal movements.
Olga Waln, Joseph Jankovic
openalex +3 more sources
Metoclopramide in Gastroparesis: Its Mechanism of Action and Safety Profile
Metoclopramide has been the cornerstone of gastroparesis management for the past 40 years as it is the only FDA-approved medication for gastroparesis. Other medications such as erythromycin and domperidone have been used off-label with variable efficacy.
M Ammar Kalas +4 more
doaj +1 more source
The purpose of the present work was to study the clinical features and risk factors of tardive dyskinesia among the schizophrenia patients who durably receive the antipsychotic therapy.
Ye. G. Kornetova +4 more
doaj +1 more source
Tardive dyskinesia is now widely recognised as a neurological disorder associated with the administration of antipsychotic drugs. Prevalence is higher among the elderly. The cause is unknown but the hypothesis of hypersensitivity of post-synaptic dopamine receptors is currently generally accepted.
V A, Portnoi, J E, Johnson
openaire +5 more sources

